iBio, Inc. Files 8-K Amendment
Ticker: IBIO · Form: 8-K/A · Filed: Apr 17, 2026 · CIK: 0001420720
Sentiment: neutral
Topics: amendment, 8-K
TL;DR
iBio filed an amendment to an 8-K, check for updated info.
AI Summary
iBio, Inc. filed an amendment (8-K/A) on April 17, 2026, to its previous report dated April 8, 2026. The amendment pertains to Item 8.01, Other Events, but the specific details of the event are not provided in the filing summary.
Why It Matters
This filing indicates a correction or addition to a previous report, suggesting a potential update to material information that could affect investors' understanding of the company's status.
Risk Assessment
Risk Level: low — The filing is an amendment to a previous report, not a new event, and lacks specific details to assess immediate risk.
Key Players & Entities
- iBio, Inc. (company) — Filer of the 8-K/A
- 0001420720 (company) — CIK number for iBio, Inc.
- 2026-04-17 (date) — Filing date of the 8-K/A
- 2026-04-08 (date) — Period of report for the original filing
FAQ
What specific event is being amended in the 8-K filing?
The filing is an amendment to Item 8.01 (Other Events) but does not specify the exact event being amended in the provided summary.
When was the original report filed that this 8-K/A amends?
The original report's period was April 8, 2026, and the amendment was filed on April 17, 2026.
What is the CIK number for iBio, Inc.?
The CIK number for iBio, Inc. is 0001420720.
What is the primary purpose of an 8-K/A filing?
An 8-K/A filing is an amendment to a previously filed Current Report on Form 8-K, used to correct or add information.
What is the business address of iBio, Inc. according to the filing?
The business address listed is 600 MADISON AVENUE, SUITE 1601, NEW YORK NY 10022-1737.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on April 17, 2026 regarding iBio, Inc. (IBIO).